SF3B1 and myelodysplastic syndrome: SF3B1 is linked to various physiological processes and metabolic pathways, such as erythropoiesis, iron metabolism, and DNA damage control (10). Mutations in SF3B1 can disrupt these pathways, alongside leading to DNA damage and increased inflammation, which may accelerate the development of MDS (10).